{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihquh3jodj3gudbxtsif3lxyvz23fmrf7purzedggafhnwny3qpwy",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnk5o3zcupr2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifvbycjyilknacnl6xoiruk6opnyshrab6xzhaasa7nxx3n3jnuqq"
    },
    "mimeType": "image/jpeg",
    "size": 122126
  },
  "path": "/news/2026-06-kidney-drug-finerenone-millions-patients.html",
  "publishedAt": "2026-06-05T06:50:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A series of major studies has shown that finerenone preserves kidney function, reduces cardiovascular risk, and improves survival across a much broader range of patients with chronic kidney disease (CKD) than it is currently recommended for. These benefits extend beyond diabetes to non-diabetic CKD and glomerular diseases.",
  "title": "Kidney drug finerenone may help millions more patients after three major studies"
}